Jacobus Pfisterer

Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG

Jacobus Pfisterer, Marie Plante, Ignace Vergote et al. · Journal of Clinical Oncology · 2006 · 751 citations · Full text

Medicine, Oncology, Pharmacology +17

Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial

Philipp Harter, Andreas du Bois, Maik Hahmann et al. · Annals of Surgical Oncology · 2006 · 422 citations

Medicine, Oncology, Surgery +16

Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study

Alexander Burges, Pauline Wimberger, Carolin Kümper et al. · Clinical Cancer Research · 2007 · 257 citations

Medicine, Oncology, Pharmacology +17

Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase

Jacek Grabowski, Philipp Harter, Florian Heitz et al. · Gynecologic Oncology · 2016 · 230 citations

Medicine, Gynecology, Oncology +16

Randomized Phase III Trial of Topotecan Following Carboplatin and Paclitaxel in First-line Treatment of Advanced Ovarian Cancer: A Gynecologic Cancer Intergroup Trial of the AGO-OVAR and GINECO

Jacobus Pfisterer, B. Weber, Rainer Kimmig et al. · JNCI Journal of the National Cancer Institute · 2006 · 209 citations

Medicine, Gynecology, Oncology +16